Robert Zivadinov, MD, PhD
Neurology
Professor and Director, Buffalo Neuroimaging Analysis Center
Buffalo Neuroimaging Analysis Center
E-2 Buffalo General Hospital
100 High St
Buffalo, NY 14203
Phone: (716) 859-7040
Fax: (716) 859-7066
Email: rz4@buffalo.edu
View Map
OFFICE LOCATIONS
|
Buffalo General Hospital 100 High St. Buffalo, NY 14203 View Map |
DESCRIPTION OF INTERESTS
| Dr. Zivadinov has acquired extensive experience in multiple sclerosis through conducting significant and progressive research, and has published more than 180 papers and 350 abstracts. At present, Dr. Zivadinov is pursuing research studies of quantitative MRI findings and venous function in multiple sclerosis as well as therapeutic interventions, including strategies towards assessing neuroprotective efforts in multiple sclerosis. His current interests also concentrate on genetic and neuroepidemiology fields of the same disease. |
SPECIALTIES
Multiple Sclerosis
Neuro Imaging
EDUCATION
| 2002 | Ph.D. in Neurology, University of Rijeka |
| 1999 | Neurology Residency, University of Trieste |
| 1995 | M.D., University of Trieste |
| 1995 | M.Sc. in Neurology, University of Rijeka |
| 1993 | M.D., University of Rijeka |
PUBLICATIONS
| Zivadinov R, Heininen-Brown M, Schirda CV, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Hagemeier J, Benedict RH, Weinstock-Guttman B, Dwyer MG; Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.; Neuroimage; 2012 Jan; 59(1); 331-339 |
| Polak P, Magnano C, Zivadinov R, Poloni G; 3D FLAIRED: 3D fluid attenuated inversion recovery for enhanced detection of lesions in multiple sclerosis.; Magn Reson Med; 2011 Dec; |
| Covey TJ, Zivadinov R, Shucard JL, Shucard DW; Information processing speed, neural efficiency, and working memory performance in multiple sclerosis: Differential relationships with structural magnetic resonance imaging.; J Clin Exp Neuropsychol; 2011 Dec; 33(10); 1129-1145 |
| Weinstock-Guttman B, Zivadinov R, Ramanathan M; Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis.; J Neurol Sci; 2011 Dec; 311(1-2); 86-91 |
| Dolic K, Weinstock-Guttman B, Marr K, Valnarov V, Carl E, Hagemeier J, Brooks C, Kilanowski C, Hojnacki D, Ramanathan M, Zivadinov R; Risk Factors for Chronic Cerebrospinal Venous Insufficiency (CCSVI) in a Large Cohort of Volunteers.; PLoS One; 2011 Nov; 6(11); 28062-28062 |
| Habib CA, Liu M, Bawany N, Garbern J, Krumbein I, Mentzel HJ, Reichenbach J, Magnano C, Zivadinov R, Haacke EM; Assessing Abnormal Iron Content in the Deep Gray Matter of Patients with Multiple Sclerosis versus Healthy Controls.; AJNR Am J Neuroradiol; 2011 Nov; |
| Zivadinov R, Marr K; Comment on "Chronic cerebrospinal venous insufficiency: have we found the cause and cure of MS?".; Neurology; 2011 Nov; 77(18); 1710-1711 |
| Zivadinov R, Poloni GU, Marr K, Schirda CV, Magnano CR, Carl E, Bergsland N, Hojnacki D, Kennedy C, Beggs CB, Dwyer MG, Weinstock-Guttman B; Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency.; BMC Neurol; 2011 Oct; 11; 128-128 |
| Weinstock-Guttman B, Zivadinov R, Mahfooz N, Carl E, Drake A, Schneider J, Teter B, Hussein S, Mehta B, Weiskopf M, Durfee J, Bergsland N, Ramanathan M; Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis.; J Neuroinflammation; 2011 Oct; 8; 127-127 |
| Zivadinov R, Ramanathan M, Dolic K, Marr K, Karmon Y, Siddiqui AH, Benedict RH, Weinstock-Guttman B; Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives.; Expert Rev Neurother; 2011 Sep; 11(9); 1277-1294 |
| O'Connor K, Weinstock-Guttman B, Carl E, Kilanowski C, Zivadinov R, Ramanathan M; Patterns of dietary and herbal supplement use by multiple sclerosis patients.; J Neurol; 2011 Sep; |
| Zamboni P, Galeotti R, Weinstock-Guttman B, Kennedy C, Salvi F, Zivadinov R; Venous Angioplasty in Patients with Multiple Sclerosis: Results of a Pilot Study.; Eur J Vasc Endovasc Surg; 2011 Aug; |
| Batista S, Zivadinov R, Hoogs M, Bergsland N, Heininen-Brown M, Dwyer MG, Weinstock-Guttman B, Benedict RH; Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis.; J Neurol; 2011 Jul; |
| Horakova D, Zivadinov R, Weinstock-Guttman B, Havrdova E, Tamaño-Blanco M, Tyblova M, Hussein S, Bergsland N, Willis L, Krasensky J, Vaneckova M, Seidl Z, Lelkova P, Ramanathan M; HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event.; J Neuroimmunol; 2011 Jul; 236(1-2); 76-80 |
| Poloni G, Minagar A, Haacke EM, Zivadinov R; Recent developments in imaging of multiple sclerosis.; Neurologist; 2011 Jul; 17(4); 185-204 |
| Antulov R, Carone DA, Bruce J, Yella V, Dwyer MG, Tjoa CW, Benedict RH, Zivadinov R; Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis.; J Neuroimaging; 2011 Jul; 21(3); 210-218 |
| Zivadinov R, Weinstock-Guttman B, Pirko I; Iron deposition and inflammation in multiple sclerosis. Which one comes first?; BMC Neurosci; 2011 Jun; 12; 60-60 |
| Mokin M, Kass-Hout T, Kass-Hout O, Zivadinov R, Mehta B; Blood Pressure Management and Evolution of Thrombolysis-associated Intracerebral Hemorrhage in Acute Ischemic Stroke.; J Stroke Cerebrovasc Dis; 2011 Jun; |
| Zivadinov R, Ramanathan M, Dwyer MG, Marr K, Benedict RH, Weinstock-Guttman B; Comment on "no evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset".; Ann Neurol; 2011 Jun; 69(6); 1062-1063 |
| Benedict RH, Zivadinov R; Risk factors for and management of cognitive dysfunction in multiple sclerosis.; Nat Rev Neurol; 2011 Jun; 7(6); 332-342 |
| Alexander JS, Zivadinov R, Maghzi AH, Ganta VC, Harris MK, Minagar A; Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms.; Pathophysiology; 2011 Feb; 18(1); 3-12 |
| Minagar A, Zivadinov R; Pathophysiology of demyelinating disorders.; Pathophysiology; 2011 Feb; 18(1); 1-2 |
| Dalaker TO, Zivadinov R, Ramasamy DP, Beyer MK, Alves G, Bronnick KS, Tysnes OB, Aarsland D, Larsen JP; Ventricular enlargement and mild cognitive impairment in early Parkinson's disease.; Mov Disord; 2011 Feb; 26(2); 297-301 |
| Dalaker TO, Zivadinov R, Ramasamy DP, Beyer MK, Alves G, Bronnick KS, Tysnes OB, Aarsland D, Larsen JP; Ventricular enlargement and mild cognitive impairment in early Parkinson's disease.; Mov Disord; 2010 Dec; |
| Dalaker TO, Zivadinov R, Larsen JP, Beyer MK, Cox JL, Alves G, Bronnick K, Tysnes OB, Antulov R, Dwyer MG, Aarsland D; Gray matter correlations of cognition in incident Parkinson's disease.; Mov Disord; 2010 Apr; 25(5); 629-633 |
| Antulov R, Carone DA, Bruce J, Yella V, Dwyer MG, Tjoa CW, Benedict RH, Zivadinov R; Regionally Distinct White Matter Lesions Do Not Contribute to Regional Gray Matter Atrophy in Patients with Multiple Sclerosis.; J Neuroimaging; 2010 Apr; |
| Minagar A, Alexander JS, Sahraian MA, Zivadinov R; Alemtuzumab and multiple sclerosis: therapeutic application.; Expert Opin Biol Ther; 2010 Mar; 10(3); 421-429 |
| Horstman LL, Jy W, Ahn YS, Zivadinov R, Maghzi AH, Etemadifar M, Steven Alexander J, Minagar A; Role of platelets in neuroinflammation: a wide-angle perspective.; J Neuroinflammation; 2010 Feb; 7; 10-10 |
| Horáková D, Kýr M, Havrdová E, Doležal O, Lelková P, Pospíšilová L, Bergsland N, Dwyer MG, Cox JL, Hussein S, Seidl Z, Vanecková M, Krásenský J, Zivadinov R; Apolipoprotein E e4-Positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study.; Folia Biol (Praha); 2010 Jan; 56(6); 242-251 |
| Dalaker TO, Larsen JP, Dwyer MG, Aarsland D, Beyer MK, Alves G, Bronnick K, Tysnes OB, Zivadinov R; White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.; Neuroimage; 2009 Oct; 47(4); 2083-2089 |
| Pirko I, Zivadinov R; Transcranial sonography of deep gray nuclei: a new outcome measure in multiple sclerosis?; Neurology; 2009 Sep; 73(13); 1006-1007 |
| Havrdova E, Zivadinov R, Krasensky J, Dwyer MG, Novakova I, Dolezal O, Ticha V, Dusek L, Houzvickova E, Cox JL, Bergsland N, Hussein S, Svobodnik A, Seidl Z, Vaneckova M, Horakova D; Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.; Mult Scler; 2009 Aug; 15(8); 965-976 |
| Zivadinov R, Minagar A; Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach.; J Neurol Sci; 2009 Jul; 282(1-2); 1-4 |
| Horakova D, Dwyer MG, Havrdova E, Cox JL, Dolezal O, Bergsland N, Rimes B, Seidl Z, Vaneckova M, Zivadinov R; Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.; J Neurol Sci; 2009 Jul; 282(1-2); 112-119 |
| Geurts JJ, Stys PK, Minagar A, Amor S, Zivadinov R; Gray matter pathology in (chronic) MS: modern views on an early observation.; J Neurol Sci; 2009 Jul; 282(1-2); 12-20 |
| Frohman EM, Dwyer MG, Frohman T, Cox JL, Salter A, Greenberg BM, Hussein S, Conger A, Calabresi P, Balcer LJ, Zivadinov R; Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study.; J Neurol Sci; 2009 Jul; 282(1-2); 96-105 |
| Schwendimann RN, Harris MK, Elliott DG, Menon U, Gonzalez-Toledo E, Zivadinov R, Pressly TA, Kelley RE, Hoque R, Fowler M, Maghzi AH, Etemadifar M, Saadatnia M, Minagar A; Neurosarcoidosis: Clinical Features, Diagnosis, and Management.; Am J Ther; 2009 May; |
| Salter AR, Conger A, Frohman TC, Zivadinov R, Eggenberger E, Calabresi P, Cutter G, Balcer L, Frohman EM; Retinal architecture predicts pupillary reflex metrics in MS.; Mult Scler; 2009 Apr; 15(4); 479-486 |
| Horstman LL, Jy W, Bidot CJ, Ahn YS, Kelley RE, Zivadinov R, Maghzi AH, Etemadifar M, Mousavi SA, Minagar A; Antiphospholipid antibodies: paradigm in transition.; J Neuroinflammation; 2009 Jan; 6; 3-3 |
| Zivadinov R; Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.; Methods Find Exp Clin Pharmacol; 2009 Jan; 31(1); 29-40 |
| Di Perri C, Dalaker TO, Beyer MK, Zivadinov R; Neuroimaging of cognitive impairments in vascular disease.; Int Rev Neurobiol; 2009 Jan; 84; 49-80 |
| Dwyer MG, Bergsland N, Saluste E, Sharma J, Jaisani Z, Durfee J, Abdelrahman N, Minagar A, Hoque R, Munschauer FE, Zivadinov R; Application of hidden Markov random field approach for quantification of perfusion/diffusion mismatch in acute ischemic stroke.; Neurol Res; 2008 Oct; 30(8); 827-834 |
| Zivadinov R, Bergsland N, Stosic M, Sharma J, Nussenbaum F, Durfee J, Hani N, Abdelrahman N, Jaisani Z, Minagar A, Hoque R, Munschauer FE, Dwyer MG; Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis.; Neurol Res; 2008 Oct; 30(8); 816-826 |
| Zivadinov R, Reder AT, Filippi M, Minagar A, Stüve O, Lassmann H, Racke MK, Dwyer MG, Frohman EM, Khan O; Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis.; Neurology; 2008 Jul; 71(2); 136-144 |
| Zivadinov R, Zorzon M, De Masi R, Nasuelli D, Cazzato G; Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis.; J Neurol Sci; 2008 Apr; 267(1-2); 28-35 |
| Horakova D, Cox JL, Havrdova E, Hussein S, Dolezal O, Cookfair D, Dwyer MG, Seidl Z, Bergsland N, Vaneckova M, Zivadinov R; Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study.; J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4); 407-414 |
| Zivadinov R, Stosic M, Cox JL, Ramasamy DP, Dwyer MG; The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome.; J Neurol; 2008 Mar; 255 S; 61-74 |
| Zivadinov R, Cox JL; Is functional MRI feasible for multi-center studies on multiple sclerosis?; Eur J Neurol; 2008 Feb; 15(2); 109-110 |
| Brass SD, Zivadinov R, Bakshi R; Acute demyelinating optic neuritis: a review.; Front Biosci; 2008 Jan; 13; 2376-2390 |
| Frohman EM, Costello F, Stüve O, Calabresi P, Miller DH, Hickman SJ, Sergott R, Conger A, Salter A, Krumwiede KH, Frohman TC, Balcer L, Zivadinov R; Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis.; Arch Neurol; 2008 Jan; 65(1); 26-35 |
| Stüve O, Bennett JL, Hemmer B, Wiendl H, Racke MK, Bar-Or A, Hu W, Zivadinov R, Weber MS, Zamvil SS, Pacheco MF, Menge T, Hartung HP, Kieseier BC, Frohman EM; Pharmacological treatment of early multiple sclerosis.; Drugs; 2008 Jan; 68(1); 73-83 |
| Frohman EM, Zivadinov R; What you see is what you get: coupling function with structure in the visual system.; Neurology; 2007 Dec; 69(23); 2119-2120 |
| Frohman EM, Shah A, Eggenberger E, Metz L, Zivadinov R, Stüve O; Corticosteroids for multiple sclerosis: I. Application for treating exacerbations.; Neurotherapeutics; 2007 Oct; 4(4); 618-626 |
| Shah A, Eggenberger E, Zivadinov R, Stüve O, Frohman EM; Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects.; Neurotherapeutics; 2007 Oct; 4(4); 627-632 |
| Zivadinov R; Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?; Neurology; 2007 May; 68(22 Su); 72-82 |
| Zivadinov R, Locatelli L, Cookfair D, Srinivasaraghavan B, Bertolotto A, Ukmar M, Bratina A, Maggiore C, Bosco A, Grop A, Catalan M, Zorzon M; Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.; Mult Scler; 2007 May; 13(4); 490-501 |
| Dolezal O, Dwyer MG, Horakova D, Havrdova E, Minagar A, Balachandran S, Bergsland N, Seidl Z, Vaneckova M, Fritz D, Krasensky J, Zivadinov R; Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis.; Int Rev Neurobiol; 2007 Jan; 79; 475-489 |
| Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto S, Zorzon M; HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.; Int Rev Neurobiol; 2007 Jan; 79; 521-535 |
| Zivadinov R, Cox JL; Neuroimaging in multiple sclerosis.; Int Rev Neurobiol; 2007 Jan; 79; 449-474 |
| Hoque R, Ledbetter C, Gonzalez-Toledo E, Misra V, Menon U, Kenner M, Rabinstein AA, Kelley RE, Zivadinov R, Minagar A; The role of quantitative neuroimaging indices in the differentiation of ischemia from demyelination: an analytical study with case presentation.; Int Rev Neurobiol; 2007 Jan; 79; 491-519 |
| Sharma J, Zivadinov R, Jaisani Z, Fabiano AJ, Singh B, Horsfield MA, Bakshi R; A magnetization transfer MRI study of deep gray matter involvement in multiple sclerosis.; J Neuroimaging; 2006 Oct; 16(4); 302-310 |
| Frohman E, Costello F, Zivadinov R, Stuve O, Conger A, Winslow H, Trip A, Frohman T, Balcer L; Optical coherence tomography in multiple sclerosis.; Lancet Neurol; 2006 Oct; 5(10); 853-863 |
| Frohman EM, Havrdova E, Lublin F, Barkhof F, Achiron A, Sharief MK, Stuve O, Racke MK, Steinman L, Weiner H, Olek M, Zivadinov R, Corboy J, Raine C, Cutter G, Richert J, Filippi M; Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.; Arch Neurol; 2006 Apr; 63(4); 614-619 |
| Frohman EM, Stüve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, Sorensen PS, Phillips JT, Weinshenker B, Hawker K, Hartung HP, Steinman L, Zamvil S, Cree BA, Hauser S, Weiner H, Racke MK, Filippi M; Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.; Arch Neurol; 2005 Oct; 62(10); 1519-1530 |
| Zorzon M, Zivadinov R, Locatelli L, Giuntini D, Toncic M, Bosco A, Nasuelli D, Bratina A, Tommasi MA, Rudick RA, Cazzato G; Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis.; Eur J Neurol; 2005 Jul; 12(7); 550-556 |
| Zivadinov R; Steroids and brain atrophy in multiple sclerosis.; J Neurol Sci; 2005 Jun; 233(1-2); 73-81 |
| Zivadinov R, Leist TP; Clinical-magnetic resonance imaging correlations in multiple sclerosis.; J Neuroimaging; 2005 Jan; 15(4 Sup); 10-21 |
| Zivadinov R, Grop A, Sharma J, Bratina A, Tjoa CW, Dwyer M, Zorzon M; Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis.; J Neuroimaging; 2005 Jan; 15(1); 27-36 |
| Locatelli L, Zivadinov R, Grop A, Zorzon M; Frontal parenchymal atrophy measures in multiple sclerosis.; Mult Scler; 2004 Oct; 10(5); 562-568 |
| Zivadinov R, Bagnato F, Nasuelli D, Bastianello S, Bratina A, Locatelli L, Watts K, Finamore L, Grop A, Dwyer M, Catalan M, Clemenzi A, Millefiorini E, Bakshi R, Zorzon M; Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.; J Neurol Sci; 2004 Aug; 223(2); 185-193 |
| Zivadinov R, Sepcic J; [Cognitive impairment in multiple sclerosis patients].; Lijec Vjesn; 2004 Jul; 126(7-8); 204-210 |
| Bagnato F, Zivadinov R, Cecchinelli D, Tancredi A, Grop A, Pierallini A, De Lena C, Prencipe M, Reale G, Zorzon M, Millefiorini E; beta2-microglobulin serum level is not a marker of disease activity in multiple sclerosis.; Eur J Neurol; 2004 Jul; 11(7); 455-460 |
| Zivadinov R, Bakshi R; Central nervous system atrophy and clinical status in multiple sclerosis.; J Neuroimaging; 2004 Jul; 14(3 Sup); 27-35 |
| Fiotti N, Zivadinov R, Altamura N, Nasuelli D, Bratina A, Tommasi MA, Bosco A, Locatelli L, Grop A, Cazzato G, Guarnieri G, Giansante C, Zorzon M; MMP-9 microsatellite polymorphism and multiple sclerosis.; J Neuroimmunol; 2004 Jul; 152(1-2); 147-153 |
| Zivadinov R, Bakshi R; Role of MRI in multiple sclerosis I: inflammation and lesions.; Front Biosci; 2004 Jan; 9; 665-683 |
| Zivadinov R, Bakshi R; Role of MRI in multiple sclerosis II: brain and spinal cord atrophy.; Front Biosci; 2004 Jan; 9; 647-664 |
| Zivadinov R, Zorzon M, Tommasi MA, Nasuelli D, Bernardi M, Monti-Bragadin L, Cazzato G; A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a.; J Neurol Sci; 2003 Dec; 216(1); 113-118 |
| Zivadinov R, Locatelli L, Stival B, Bratina A, Grop A, Nasuelli D, Brnabic-Razmilic O, Zorzon M; Normalized regional brain atrophy measurements in multiple sclerosis.; Neuroradiology; 2003 Nov; 45(11); 793-798 |
| Zorzon M, Zivadinov R, Nasuelli D, Dolfini P, Bosco A, Bratina A, Tommasi MA, Locatelli L, Cazzato G; Risk factors of multiple sclerosis: a case-control study.; Neurol Sci; 2003 Nov; 24(4); 242-247 |
| Zivadinov R, Uxa L, Zacchi T, Nasuelli D, Ukmar M, Furlan C, Pozzi-Mucelli R, Tommasi MA, Locatelli L, Ulivi S, Bratina A, Bosco A, Grop A, Cazzato G, Zorzon M; HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis.; J Neurol; 2003 Sep; 250(9); 1099-1106 |
| Zivadinov R, Willheim K, Sepic-Grahovac D, Jurjevic A, Bucuk M, Brnabic-Razmilic O, Relja G, Zorzon M; Migraine and tension-type headache in Croatia: a population-based survey of precipitating factors.; Cephalalgia; 2003 Jun; 23(5); 336-343 |
| Zivadinov R, Zorzon M, Locatelli L, Stival B, Monti F, Nasuelli D, Tommasi MA, Bratina A, Cazzato G; Sexual dysfunction in multiple sclerosis: a MRI, neurophysiological and urodynamic study.; J Neurol Sci; 2003 Jun; 210(1-2); 73-76 |
| Zorzon M, Zivadinov R, Locatelli L, Stival B, Nasuelli D, Bratina A, Bosco A, Tommasi MA, Pozzi Mucelli RS, Ukmar M, Cazzato G; Correlation of sexual dysfunction and brain magnetic resonance imaging in multiple sclerosis.; Mult Scler; 2003 Feb; 9(1); 108-110 |
| Zivadinov R, Iona L, Monti-Bragadin L, Bosco A, Jurjevic A, Taus C, Cazzato G, Zorzon M; The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study.; Neuroepidemiology; 2003 Jan; 22(1); 65-74 |
| Zivadinov R, Zorzon M; Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature.; J Neuroimaging; 2002 Oct; 12(4); 302-309 |
| Zorzon M, Zivadinov R, Nasuelli D, Ukmar M, Bratina A, Tommasi MA, Mucelli RP, Brnabic-Razmilic O, Grop A, Bonfigli L, Cazzato G; Depressive symptoms and MRI changes in multiple sclerosis.; Eur J Neurol; 2002 Sep; 9(5); 491-496 |
| Zorzon M, Capus L, Pellegrino A, Cazzato G, Zivadinov R; Familial and environmental risk factors in Parkinson's disease: a case-control study in north-east Italy.; Acta Neurol Scand; 2002 Feb; 105(2); 77-82 |
| Zivadinov R, Rudick RA, De Masi R, Nasuelli D, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M; Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.; Neurology; 2001 Oct; 57(7); 1239-1247 |
| Zivadinov R, Willheim K, Jurjevic A, Sepic-Grahovac D, Bucuk M, Zorzon M; Prevalence of migraine in Croatia: a population-based survey.; Headache; 2001 Sep; 41(8); 805-812 |
| Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi MA, Zambito-Marsala S, Moretti R, Bratina A, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M; A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.; J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6); 773-780 |
| Moretti R, Bava A, Torre P, Antonello RM, Zorzon M, Zivadinov R, Cazzato G; Bilingual aphasia and subcortical-cortical lesions.; Percept Mot Skills; 2001 Jun; 92(3 Pt); 803-814 |
| Zorzon M, Zivadinov R, Monti Bragadin L, Moretti R, De Masi R, Nasuelli D, Cazzato G; Sexual dysfunction in multiple sclerosis: a 2-year follow-up study.; J Neurol Sci; 2001 Jun; 187(1-2); 1-5 |
| Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, Bratina A, Zivadinov R; Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects.; J Neurol; 2001 May; 248(5); 416-421 |
| Zivadinov R, De Masi R, Nasuelli D, Bragadin LM, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M; MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis.; Neuroradiology; 2001 Apr; 43(4); 272-278 |
| Zorzon M, Ukmar M, Bragadin LM, Zanier F, Antonello RM, Cazzato G, Zivadinov R; Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: a clinical and MR study.; Mult Scler; 2000 Dec; 6(6); 386-390 |
| Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Morassi P, Iona LG, Cazzato G; Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups.; Mult Scler; 1999 Dec; 5(6); 418-427 |
| Zivadinov R, Zorzon M, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Iona LG, Cazzato G; Sexual dysfunction in multiple sclerosis: II. Correlation analysis.; Mult Scler; 1999 Dec; 5(6); 428-431 |
| Cazzato G, Antonello RM, Zorzon M, Torre P, Zivadinov R, Moretti R, Bragadin LM, De Masi R, Nasuelli D; [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].; Recenti Prog Med; 1999 Oct; 90(10); 538-544 |
| Zivadinov R, Zorzon M, Monti Bragadin L, Pagliaro G, Cazzato G; Olfactory loss in multiple sclerosis.; J Neurol Sci; 1999 Oct; 168(2); 127-130 |
| Zivadinov R, Jurjevic A, Willheim K, Cazzato G, Zorzon M; Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996.; Neuroepidemiology; 1998 Jan; 17(5); 265-272 |
GRANTS
January 2011 to December 2011
Interactive web-based continuing medical education (CME) program: Managing Parkinson‘s Disease: Diagnosis and Treatment Problems and Solutions
Biogen Idec, Inc.
Robert Zivadinov
January 2011 to December 2011
Neurology Lecture Series
Teva Neuroscience, Inc.
Robert Zivadinov
October 2010 to December 2011
Interactive web-based continuing medical education (CME) program: Understanding Multiple Sclerosis: Advances in Epidemiology, Pathology, Imaging and Treatment Strategies
Teva Neuroscience, Inc.
Robert Zivadinov
September 2010 to September 2013
Gene-Environmental Interactions in Progression of Multiple Sclerosis
Department of Defense Multiple Sclerosis Research Program of the Office of the Congressionally Directed Medical Research Program
Robert Zivadinov
January 2010 to December 2011
Magnetic resonance imaging (MRI testing of active implantable medical devices (AIMDs)
Greatbatch Medical
Robert Zivadinov
December 2009 to December 2012
A multinational, multicenter, randomized, parallel-group study performed in subjects with Relapsing-Remitting Multiple Sclerosis (RRMS) to assess the efficacy, safety and tolerability of Glatiramer Acetate (GA) injection 40 mg/ml administered three times
Teva Pharmacuticals, Inc.
Robert Zivadinov
December 2009 to December 2011
Combined transcranial and extracranial venous Doppler evaluation (CTEVD study). Description of the design and interim results of an epidemiological study of the prevalence of chronic cerebrospinal venous insufficiency in MS and related diseases
Direct MS Foundation, Jacquemin Foundation, Bronfman Foundation
Robert Zivadinov
December 2009 to December 2011
Natalizumab Temporary Discontinuation Study (NaTDS)
Biogen Idec, Inc.
Robert Zivadinov
December 2009 to December 2011
PREMiSe Trial: Prospective Randomized Endovascular therapy in Multiple Sclerosis
Direct MS Foundation
Robert Zivadinov
September 2009 to December 2012
A twenty-four week, two arm, pilot trial to evaluate remyelination/demyelination, gray matter volume and iron deposition in the central nervous system (CNS) and immune status of subjects with relapsing-remitting multiple sclerosis (RRMS) treated with Reb
EMD Serono Inc.
Robert Zivadinov
February 2009 to June 2013
Evolution of gray matter (GM) atrophy over 4 years in observational study of early interferon (IFN)β-1a intramuscular (I.M.) (Avonex® ) treatment in high risk subjects after clinically isolated syndrome (SET substudy)
Biogen Idec, Inc.
Robert Zivadinov
October 2008 to December 2011
BDNF in multiple sclerosis (Renewal).
National Multiple Sclerosis Society
Robert Zivadinov
October 2008 to September 2012
Longitudinal analysis of regional brain atrophy and personality change in MS
National Multiple Sclerosis Society
Robert Zivadinov